SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Warns Heartburn Drugs Interfere with Sanofi-Aventis (France), Bristol-Myers Squibb Company’s (JOBS) Plavix

November 18, 2009 | 
1 min read

Bookmark and Share

Reuters -- Common heartburn pills Prilosec and Nexium cut the blood-thinning effect of Sanofi-Aventis SA’s (SASY.PA) and Bristol-Myers Squibb Co’s (BMY.N) heart drug Plavix, U.S. officials warned on Tuesday.

FDA Approvals
Bristol Myers Squibb Company Food and Drug Administration (FDA) Sanofi (France)
MORE ON THIS TOPIC
Novo Nordisk advertising flags and logo on facade
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
December 12, 2024
 · 
1 min read
 · 
Kate Goodwin
Mental health, illness ,brain development ,medical treatment concept, messy lines of thinks in human head , vector illustration
Neurodegenerative disease
UniQure Clears Path to Accelerated Approval for Huntington’s Gene Therapy
December 10, 2024
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: Ionis, Lexicon, Bristol Myers Squibb and More
December 9, 2024
 · 
7 min read
 · 
Tristan Manalac
Contemporary collage with a running clock and an arrow. Planning and time management concept.
Regulatory
FDA Outlines Accelerated Review Guidelines in Waning Days of Biden Administration
December 6, 2024
 · 
3 min read
 · 
Annalee Armstrong